Anixa’s Ovarian Cancer Trial Progress: Promising Results
Anixa Biosciences advances Phase 1 clinical trial for ovarian cancer therapy, increasing dosage and showing promising results. Market responds positively ...
- Latest
- Trending
Anixa Biosciences advances Phase 1 clinical trial for ovarian cancer therapy, increasing dosage and showing promising results. Market responds positively ...
The stock market continues to rise with the support of the Federal Reserve's financial aid. The Nasdaq and S&P 500 ...
Kintara Therapeutics has launched a clinical trial for REM-001, a promising treatment for cutaneous metastatic breast cancer. The trial aims ...
UBS predicts S&P 500 will reach 5,300, exceeding 7% growth rate. Positive earnings and economic outlook contribute to optimistic market ...
W. P. Carey & Co. faces downgrade and concerns after stock decline due to credit issues and non-renewal, but oversold ...
Invizyne Technologies files registration statement with SEC for public offering. Offering consists of 4.3 million shares priced at $4.00 per ...
Benchmark analysts maintain their Sell rating for The Trade Desk Inc. due to revenue concerns and predict a possible stock ...
Dow Jones futures fell ahead of the consumer price index inflation report, causing market sentiment to be cautious. Investors are ...
Excitement builds among Dogecoin holders as the Dogecoin Foundation unveils ambitious 2024 goals, while Kelexo emerges as an AI-powered game-changer ...
The Dow Jones ends the week with minimal changes, while the Nasdaq approaches a record high. Fed officials highlight the ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.